British Columbia Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.82M | Buy |
|
|||||
|
2024
Q3 | $1.69M | Sell |
|
|||||
|
2024
Q2 | $2.03M | Sell |
|
|||||
|
2024
Q1 | $13.9M | Buy |
|
|||||
|
2023
Q4 | $12M | Buy |
|
|||||
|
2023
Q3 | $9.73M | Buy |
|
|||||
|
2023
Q2 | $9.59M | Buy |
|
|||||
|
2023
Q1 | $9.19M | Buy |
|
|||||
|
2022
Q4 | $9.91M | Buy |
|
|||||
|
2022
Q3 | $6.89M | Buy |
|
|||||
|
2022
Q2 | $5.83M | Sell |
|
|||||
|
2022
Q1 | $9.14M | Sell |
|
|||||
|
2021
Q4 | $15.5M | Sell |
|
|||||
|
2021
Q3 | $18.4M | Sell |
|
|||||
|
2021
Q2 | $23.4M | Buy |
|
|||||
|
2021
Q1 | $15.6M | Sell |
|
|||||
|
2020
Q4 | $15M | Sell |
|
|||||
|
2020
Q3 | $15.3M | Sell |
|
|||||
|
2020
Q2 | $12.7M | Buy |
|
|||||
|
2020
Q1 | $5.77M | Buy |
|
|||||
|
2019
Q4 | $3.25M | Buy |
|